| Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ... Cell, 2020 | 1333 | 2020 |
| Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel HF Günthard, MS Saag, CA Benson, C del Rio, JJ Eron, JE Gallant, ... JAMA 316 (2), 191-210, 2016 | 614 | 2016 |
| Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... BioRxiv, 2020 | 500* | 2020 |
| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 498 | 2020 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... JAMA 320 (4), 379-396, 2018 | 463 | 2018 |
| Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection RT Schooley, B Biswas, JJ Gill, A Hernandez-Morales, J Lancaster, ... Antimicrobial agents and chemotherapy 61 (10), 2017 | 461 | 2017 |
| Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection SD Frost, T Wrin, DM Smith Proc Natl Acad Sci USA 102 (51), 18514-9, 2005 | 403* | 2005 |
| Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy T Le, EJ Wright, DM Smith, W He, G Catano, JF Okulicz, JA Young, ... New England Journal of Medicine 368 (3), 218-230, 2013 | 371 | 2013 |
| Kosakovsky Pond SL. 2012. Detecting individual sites subject to episodic diversifying selection B Murrell, JO Wertheim, S Moola, T Weighill, K Scheffler PLoS Genet 8 (7), e1002764, 0 | 365 | |
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia SM Dillon, EJ Lee, CV Kotter, GL Austin, Z Dong, DK Hecht, S Gianella, ... Mucosal immunology 7 (4), 983-994, 2014 | 341 | 2014 |
| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 318 | 2020 |
| Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ... Clinical Infectious Diseases 60 (3), 473-480, 2015 | 278 | 2015 |
| Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence MC Strain, HF Günthard, DV Havlir, CC Ignacio, DM Smith, ... Proceedings of the National Academy of Sciences 100 (8), 4819-4824, 2003 | 278 | 2003 |
| HIV superinfection DM Smith, DD Richman, SJ Little The Journal of infectious diseases 192 (3), 438-444, 2005 | 270 | 2005 |
| Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline I Grant, DR Franklin, R Deutsch, SP Woods, F Vaida, RJ Ellis, ... Neurology 82 (23), 2055-2062, 2014 | 262 | 2014 |
| Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection SJ Little, SDW Frost, JK Wong, DM Smith, SLK Pond, CC Ignacio, ... Journal of virology 82 (11), 5510-5518, 2008 | 242 | 2008 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS Med 12 (4), e1001810, 2015 | 231 | 2015 |
| Gene-wide identification of episodic selection B Murrell, S Weaver, MD Smith, JO Wertheim, S Murrell, A Aylward, ... Molecular biology and evolution 32 (5), 1365-1371, 2015 | 229 | 2015 |
| Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell, 2020 | 209 | 2020 |
| The global transmission network of HIV-1 JO Wertheim, AJ Leigh Brown, NL Hepler, SR Mehta, DD Richman, ... The Journal of infectious diseases 209 (2), 304-313, 2014 | 197 | 2014 |
